260 related articles for article (PubMed ID: 30773433)
1. HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: Promises and challenges.
Nnodu O; Isa H; Nwegbu M; Ohiaeri C; Adegoke S; Chianumba R; Ugwu N; Brown B; Olaniyi J; Okocha E; Lawson J; Hassan AA; Diaku-Akinwumi I; Madu A; Ezenwosu O; Tanko Y; Kangiwa U; Girei A; Israel-Aina Y; Ladu A; Egbuzu P; Abjah U; Okolo A; Akbulut-Jeradi N; Fernandez M; Piel FB; Adekile A
Blood Cells Mol Dis; 2019 Sep; 78():22-28. PubMed ID: 30773433
[TBL] [Abstract][Full Text] [Related]
2. Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study.
Nnodu OE; Sopekan A; Nnebe-Agumadu U; Ohiaeri C; Adeniran A; Shedul G; Isa HA; Owolabi O; Chianumba RI; Tanko Y; Iyobosa JH; Adekile AD; Olopade OI; Piel FB
Lancet Haematol; 2020 Jul; 7(7):e534-e540. PubMed ID: 32589979
[TBL] [Abstract][Full Text] [Related]
3. Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test.
Steele C; Sinski A; Asibey J; Hardy-Dessources MD; Elana G; Brennan C; Odame I; Hoppe C; Geisberg M; Serrao E; Quinn CT
Am J Hematol; 2019 Jan; 94(1):39-45. PubMed ID: 30290004
[TBL] [Abstract][Full Text] [Related]
4. Saving lives through early diagnosis: the promise and role of point of care testing for sickle cell disease.
Dexter D; McGann PT
Br J Haematol; 2022 Jan; 196(1):63-69. PubMed ID: 34340260
[TBL] [Abstract][Full Text] [Related]
5. A rapid, inexpensive and disposable point-of-care blood test for sickle cell disease using novel, highly specific monoclonal antibodies.
Quinn CT; Paniagua MC; DiNello RK; Panchal A; Geisberg M
Br J Haematol; 2016 Nov; 175(4):724-732. PubMed ID: 27605462
[TBL] [Abstract][Full Text] [Related]
6. Multicenter Evaluation of HemoTypeSC as a Point-of-Care Sickle Cell Disease Rapid Diagnostic Test for Newborns and Adults Across India.
Mukherjee MB; Colah RB; Mehta PR; Shinde N; Jain D; Desai S; Dave K; Italia Y; Raicha B; Serrao E
Am J Clin Pathol; 2020 Jan; 153(1):82-87. PubMed ID: 31433854
[TBL] [Abstract][Full Text] [Related]
7. Feasibility and acceptability of early infant screening for sickle cell disease in Lagos, Nigeria-A pilot study.
Oluwole EO; Adeyemo TA; Osanyin GE; Odukoya OO; Kanki PJ; Afolabi BB
PLoS One; 2020; 15(12):e0242861. PubMed ID: 33270733
[TBL] [Abstract][Full Text] [Related]
8. Newborn Screening for Sickle Cell Disease Using Point-of-Care Testing in Low-Income Setting.
Alvarez OA; Hustace T; Voltaire M; Mantero A; Liberus U; Saint Fleur R
Pediatrics; 2019 Oct; 144(4):. PubMed ID: 31530717
[TBL] [Abstract][Full Text] [Related]
9. Determination of birth prevalence of sickle cell disease using point of care test HemotypeSC™ at Rundu Hospital, Namibia.
Mano RM; Kuona P; Misihairabgwi JM
BMC Pediatr; 2024 May; 24(1):323. PubMed ID: 38730340
[TBL] [Abstract][Full Text] [Related]
10. Towards a point-of-care strip test to diagnose sickle cell anemia.
Bond M; Hunt B; Flynn B; Huhtinen P; Ware R; Richards-Kortum R
PLoS One; 2017; 12(5):e0177732. PubMed ID: 28520780
[TBL] [Abstract][Full Text] [Related]
11. Potential of point of care tests for newborn screening for sickle cell disease: Evaluation of HemotypeSC™ and sickle SCAN® in Tanzania.
Christopher H; Josephat E; Kaywanga F; Saul S; Mshana I; Kunambi P; Nasser A; Chamba C; Makani J; Nkya S
Int J Lab Hematol; 2022 Oct; 44(5):959-965. PubMed ID: 35775883
[TBL] [Abstract][Full Text] [Related]
12. Potential for a large-scale newborn screening strategy for sickle cell disease in Mali: A comparative diagnostic performance study of two rapid diagnostic tests (SickleScan® and HemotypeSC®) on cord blood.
Guindo A; Cisse Z; Keita I; Desmonde S; Sarro YDS; Touré BA; Baraika MA; Tessougué O; Guindo P; Coulibaly M; Traore O; Sylla N; Diassana M; Saye A; Picot V; Lauressergues E; Leroy V
Br J Haematol; 2024 Jan; 204(1):337-345. PubMed ID: 37728227
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous point-of-care detection of anemia and sickle cell disease in Tanzania: the RAPID study.
Smart LR; Ambrose EE; Raphael KC; Hokororo A; Kamugisha E; Tyburski EA; Lam WA; Ware RE; McGann PT
Ann Hematol; 2018 Feb; 97(2):239-246. PubMed ID: 29147848
[TBL] [Abstract][Full Text] [Related]
14. Early diagnosis of sickle cell disease at birth hospitals and vaccination centers in Angola using point-of-care tests.
Olaniyan HS; Briscoe C; Muhongo M; Pascoal R; Armando A; Santos B; McGann PT
Blood Adv; 2023 Oct; 7(19):5860-5867. PubMed ID: 37399450
[TBL] [Abstract][Full Text] [Related]
15. A prospective newborn screening and treatment program for sickle cell anemia in Luanda, Angola.
McGann PT; Ferris MG; Ramamurthy U; Santos B; de Oliveira V; Bernardino L; Ware RE
Am J Hematol; 2013 Dec; 88(12):984-9. PubMed ID: 24038490
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of a rapid, point-of-care lateral flow immunoassay for the diagnosis of sickle cell disease.
McGann PT; Schaefer BA; Paniagua M; Howard TA; Ware RE
Am J Hematol; 2016 Feb; 91(2):205-10. PubMed ID: 26537622
[TBL] [Abstract][Full Text] [Related]
17. [Targeted newborn screening for sickle-cell anemia: Sickling test (Emmel test) boundaries in the prenatal assessment in West African area].
Diallo DA; Guindo A; Touré BA; Sarro YS; Sima M; Tessougué O; Baraika MA; Guindo P; Traoré M; Diallo M; Dorie A
Rev Epidemiol Sante Publique; 2018 May; 66(3):181-185. PubMed ID: 29625861
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a Portable Haemoglobin Metre Performance in Children with Sickle Cell Disease and Implications for Healthcare in Resource-poor Settings.
Olatunya OS; Olu-Taiwo A; Ogundare EO; Oluwayemi IO; Olaleye AO; Fadare JO; Adekoya-Benson T; Fatunla O; Agaja OT; Omoniyi E; Oluwadiya KS
J Trop Pediatr; 2016 Aug; 62(4):316-23. PubMed ID: 26995011
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyurea for children with sickle cell disease in sub-Saharan Africa: A summary of the evidence, opportunities, and challenges.
Dexter D; McGann PT
Pharmacotherapy; 2023 May; 43(5):430-441. PubMed ID: 36906823
[TBL] [Abstract][Full Text] [Related]
20. Extremely high birth prevalence of sickle cell disease in rural Tanzania.
Eastburg L; Peckham A; Kawira E; Chirangi B; Adler D; Akungo BD; Smart LR; Ambrose EE
Pediatr Blood Cancer; 2020 Nov; 67(11):e28620. PubMed ID: 32803850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
